Which has higher valuation and earnings, TFX or STE?

STERIS has higher revenue and earnings than Teleflex. Teleflex is trading at a lower price-to-earnings ratio than STERIS, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Teleflex $1.99B 3.02 -$905.64M -$22.80 N/A STERIS $5.94B 3.49 $782.30M $7.93 26.79

Is TFX or STE more profitable?

STERIS has a net margin of 13.18% compared to Teleflex's net margin of -35.88%. STERIS's return on equity of 14.15% beat Teleflex's return on equity. Company Net Margins Return on Equity Return on Assets Teleflex -35.88% 13.29% 6.55% STERIS 13.18% 14.15% 9.52%

Does the media refer more to TFX or STE?

In the previous week, STERIS had 12 more articles in the media than Teleflex. MarketBeat recorded 18 mentions for STERIS and 6 mentions for Teleflex. STERIS's average media sentiment score of 0.82 beat Teleflex's score of 0.52 indicating that STERIS is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Teleflex 3 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive STERIS 11 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable valuation and earnings, TFX or GMED?

Globus Medical has higher revenue and earnings than Teleflex. Teleflex is trading at a lower price-to-earnings ratio than Globus Medical, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Teleflex $1.99B 3.02 -$905.64M -$22.80 N/A Globus Medical $2.94B 3.82 $537.87M $4.30 19.21

Is TFX or GMED more profitable?

Globus Medical has a net margin of 18.92% compared to Teleflex's net margin of -35.88%. Globus Medical's return on equity of 13.46% beat Teleflex's return on equity. Company Net Margins Return on Equity Return on Assets Teleflex -35.88% 13.29% 6.55% Globus Medical 18.92% 13.46% 11.65%

Does the media refer more to TFX or GMED?

In the previous week, Teleflex had 1 more articles in the media than Globus Medical. MarketBeat recorded 6 mentions for Teleflex and 5 mentions for Globus Medical. Globus Medical's average media sentiment score of 0.54 beat Teleflex's score of 0.52 indicating that Globus Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Teleflex 3 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Globus Medical 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher earnings & valuation, TFX or PODD?

Insulet has higher revenue and earnings than Teleflex. Teleflex is trading at a lower price-to-earnings ratio than Insulet, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Teleflex $1.99B 3.02 -$905.64M -$22.80 N/A Insulet $2.71B 4.08 $247.10M $4.30 37.12

Is TFX or PODD more profitable?

Insulet has a net margin of 10.44% compared to Teleflex's net margin of -35.88%. Insulet's return on equity of 26.87% beat Teleflex's return on equity. Company Net Margins Return on Equity Return on Assets Teleflex -35.88% 13.29% 6.55% Insulet 10.44% 26.87% 12.01%

Does the media prefer TFX or PODD?

In the previous week, Insulet had 18 more articles in the media than Teleflex. MarketBeat recorded 24 mentions for Insulet and 6 mentions for Teleflex. Insulet's average media sentiment score of 0.94 beat Teleflex's score of 0.52 indicating that Insulet is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Teleflex 3 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Insulet 12 Very Positive mention(s) 3 Positive mention(s) 5 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to TFX or BAX?

In the previous week, Teleflex had 3 more articles in the media than Baxter International. MarketBeat recorded 6 mentions for Teleflex and 3 mentions for Baxter International. Baxter International's average media sentiment score of 0.59 beat Teleflex's score of 0.52 indicating that Baxter International is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Teleflex 3 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Baxter International 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable earnings and valuation, MASI or TFX?

Masimo has higher earnings, but lower revenue than Teleflex. Masimo is trading at a lower price-to-earnings ratio than Teleflex, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Masimo $1.53B 6.17 -$151.50M -$10.54 N/A Teleflex $1.99B 3.02 -$905.64M -$22.80 N/A

Is MASI or TFX more profitable?

Masimo has a net margin of 4.90% compared to Teleflex's net margin of -35.88%. Masimo's return on equity of 31.33% beat Teleflex's return on equity. Company Net Margins Return on Equity Return on Assets Masimo 4.90% 31.33% 13.93% Teleflex -35.88% 13.29% 6.55%

Does the media prefer MASI or TFX?

In the previous week, Masimo and Masimo both had 6 articles in the media. Masimo's average media sentiment score of 0.66 beat Teleflex's score of 0.52 indicating that Masimo is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Masimo 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Teleflex 3 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Teleflex (TFX) Competitors

$135.82 +4.08 (+3.10%)

Closing price 06/9/2026 03:59 PM Eastern

Extended Trading

$135.60 -0.22 (-0.16%)

As of 06/9/2026 04:10 PM Eastern

Compare

TFX vs. STE, GMED, PODD, BAX, and MASI

Should you buy Teleflex stock or one of its competitors? MarketBeat compares Teleflex with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Teleflex include STERIS (STE), Globus Medical (GMED), Insulet (PODD), Baxter International (BAX), and Masimo (MASI). These companies are all part of the "health care equipment" industry.

How does Teleflex compare to STERIS?

Teleflex (NYSE:TFX) and STERIS (NYSE:STE) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, media sentiment, institutional ownership, profitability, earnings and risk.

Teleflex has a beta of 0.82, suggesting that its stock price is 18% less volatile than the broader market. Comparatively, STERIS has a beta of 0.93, suggesting that its stock price is 7% less volatile than the broader market.

STERIS has a net margin of 13.18% compared to Teleflex's net margin of -35.88%. STERIS's return on equity of 14.15% beat Teleflex's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Teleflex	-35.88%	13.29%	6.55%
STERIS	13.18%	14.15%	9.52%

Teleflex pays an annual dividend of $1.36 per share and has a dividend yield of 1.0%. STERIS pays an annual dividend of $2.52 per share and has a dividend yield of 1.2%. Teleflex pays out -6.0% of its earnings in the form of a dividend. STERIS pays out 31.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. STERIS has increased its dividend for 20 consecutive years. STERIS is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

STERIS has higher revenue and earnings than Teleflex. Teleflex is trading at a lower price-to-earnings ratio than STERIS, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Teleflex	$1.99B	3.02	-$905.64M	-$22.80	N/A
STERIS	$5.94B	3.49	$782.30M	$7.93	26.79

Teleflex presently has a consensus price target of $146.00, suggesting a potential upside of 7.49%. STERIS has a consensus price target of $278.00, suggesting a potential upside of 30.87%. Given STERIS's stronger consensus rating and higher possible upside, analysts clearly believe STERIS is more favorable than Teleflex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Teleflex	1 Sell rating(s)	5 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.30
STERIS	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75

95.6% of Teleflex shares are owned by institutional investors. Comparatively, 94.7% of STERIS shares are owned by institutional investors. 0.7% of Teleflex shares are owned by insiders. Comparatively, 1.1% of STERIS shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, STERIS had 12 more articles in the media than Teleflex. MarketBeat recorded 18 mentions for STERIS and 6 mentions for Teleflex. STERIS's average media sentiment score of 0.82 beat Teleflex's score of 0.52 indicating that STERIS is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Teleflex	3 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
STERIS	11 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

STERIS beats Teleflex on 16 of the 19 factors compared between the two stocks.

How does Teleflex compare to Globus Medical?

Teleflex (NYSE:TFX) and Globus Medical (NYSE:GMED) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, risk, valuation, media sentiment, analyst recommendations, institutional ownership and dividends.

In the previous week, Teleflex had 1 more articles in the media than Globus Medical. MarketBeat recorded 6 mentions for Teleflex and 5 mentions for Globus Medical. Globus Medical's average media sentiment score of 0.54 beat Teleflex's score of 0.52 indicating that Globus Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Teleflex	3 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Globus Medical	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Teleflex currently has a consensus target price of $146.00, indicating a potential upside of 7.49%. Globus Medical has a consensus target price of $106.36, indicating a potential upside of 28.77%. Given Globus Medical's stronger consensus rating and higher possible upside, analysts plainly believe Globus Medical is more favorable than Teleflex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Teleflex	1 Sell rating(s)	5 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.30
Globus Medical	0 Sell rating(s)	4 Hold rating(s)	9 Buy rating(s)	2 Strong Buy rating(s)	2.87

95.6% of Teleflex shares are owned by institutional investors. Comparatively, 95.2% of Globus Medical shares are owned by institutional investors. 0.7% of Teleflex shares are owned by insiders. Comparatively, 18.4% of Globus Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Teleflex has a beta of 0.82, meaning that its share price is 18% less volatile than the broader market. Comparatively, Globus Medical has a beta of 0.95, meaning that its share price is 5% less volatile than the broader market.

Globus Medical has a net margin of 18.92% compared to Teleflex's net margin of -35.88%. Globus Medical's return on equity of 13.46% beat Teleflex's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Teleflex	-35.88%	13.29%	6.55%
Globus Medical	18.92%	13.46%	11.65%

Globus Medical has higher revenue and earnings than Teleflex. Teleflex is trading at a lower price-to-earnings ratio than Globus Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Teleflex	$1.99B	3.02	-$905.64M	-$22.80	N/A
Globus Medical	$2.94B	3.82	$537.87M	$4.30	19.21

Summary

Globus Medical beats Teleflex on 15 of the 17 factors compared between the two stocks.

How does Teleflex compare to Insulet?

Teleflex (NYSE:TFX) and Insulet (NASDAQ:PODD) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, earnings, media sentiment, institutional ownership, profitability and dividends.

95.6% of Teleflex shares are held by institutional investors. 0.7% of Teleflex shares are held by company insiders. Comparatively, 0.4% of Insulet shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Insulet has a net margin of 10.44% compared to Teleflex's net margin of -35.88%. Insulet's return on equity of 26.87% beat Teleflex's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Teleflex	-35.88%	13.29%	6.55%
Insulet	10.44%	26.87%	12.01%

Insulet has higher revenue and earnings than Teleflex. Teleflex is trading at a lower price-to-earnings ratio than Insulet, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Teleflex	$1.99B	3.02	-$905.64M	-$22.80	N/A
Insulet	$2.71B	4.08	$247.10M	$4.30	37.12

Teleflex has a beta of 0.82, meaning that its stock price is 18% less volatile than the broader market. Comparatively, Insulet has a beta of 1.13, meaning that its stock price is 13% more volatile than the broader market.

In the previous week, Insulet had 18 more articles in the media than Teleflex. MarketBeat recorded 24 mentions for Insulet and 6 mentions for Teleflex. Insulet's average media sentiment score of 0.94 beat Teleflex's score of 0.52 indicating that Insulet is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Teleflex	3 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Insulet	12 Very Positive mention(s)	3 Positive mention(s)	5 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Teleflex presently has a consensus price target of $146.00, suggesting a potential upside of 7.49%. Insulet has a consensus price target of $250.00, suggesting a potential upside of 56.63%. Given Insulet's stronger consensus rating and higher possible upside, analysts clearly believe Insulet is more favorable than Teleflex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Teleflex	1 Sell rating(s)	5 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.30
Insulet	1 Sell rating(s)	5 Hold rating(s)	21 Buy rating(s)	0 Strong Buy rating(s)	2.74

Summary

Insulet beats Teleflex on 14 of the 16 factors compared between the two stocks.

How does Teleflex compare to Baxter International?

Teleflex (NYSE:TFX) and Baxter International (NYSE:BAX) are both mid-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, earnings, institutional ownership, valuation, dividends, profitability and media sentiment.

Teleflex has a beta of 0.82, indicating that its share price is 18% less volatile than the broader market. Comparatively, Baxter International has a beta of 0.64, indicating that its share price is 36% less volatile than the broader market.

Teleflex currently has a consensus target price of $146.00, suggesting a potential upside of 7.49%. Baxter International has a consensus target price of $19.73, suggesting a potential downside of 1.57%. Given Teleflex's stronger consensus rating and higher probable upside, equities analysts plainly believe Teleflex is more favorable than Baxter International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Teleflex	1 Sell rating(s)	5 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.30
Baxter International	3 Sell rating(s)	8 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	1.92

Teleflex pays an annual dividend of $1.36 per share and has a dividend yield of 1.0%. Baxter International pays an annual dividend of $0.04 per share and has a dividend yield of 0.2%. Teleflex pays out -6.0% of its earnings in the form of a dividend. Baxter International pays out -1.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Teleflex is clearly the better dividend stock, given its higher yield and lower payout ratio.

Teleflex has higher earnings, but lower revenue than Baxter International. Baxter International is trading at a lower price-to-earnings ratio than Teleflex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Teleflex	$1.99B	3.02	-$905.64M	-$22.80	N/A
Baxter International	$11.24B	0.92	-$957M	-$2.13	N/A

Baxter International has a net margin of -9.70% compared to Teleflex's net margin of -35.88%. Baxter International's return on equity of 16.15% beat Teleflex's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Teleflex	-35.88%	13.29%	6.55%
Baxter International	-9.70%	16.15%	5.24%

95.6% of Teleflex shares are held by institutional investors. Comparatively, 90.2% of Baxter International shares are held by institutional investors. 0.7% of Teleflex shares are held by insiders. Comparatively, 0.2% of Baxter International shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, Teleflex had 3 more articles in the media than Baxter International. MarketBeat recorded 6 mentions for Teleflex and 3 mentions for Baxter International. Baxter International's average media sentiment score of 0.59 beat Teleflex's score of 0.52 indicating that Baxter International is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Teleflex	3 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Baxter International	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Teleflex beats Baxter International on 13 of the 18 factors compared between the two stocks.

How does Teleflex compare to Masimo?

Masimo (NASDAQ:MASI) and Teleflex (NYSE:TFX) are both mid-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, media sentiment, valuation, risk, profitability, analyst recommendations, earnings and institutional ownership.

In the previous week, Masimo and Masimo both had 6 articles in the media. Masimo's average media sentiment score of 0.66 beat Teleflex's score of 0.52 indicating that Masimo is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Masimo	1 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Teleflex	3 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

86.0% of Masimo shares are owned by institutional investors. Comparatively, 95.6% of Teleflex shares are owned by institutional investors. 16.9% of Masimo shares are owned by insiders. Comparatively, 0.7% of Teleflex shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Masimo has a beta of 1.11, suggesting that its stock price is 11% more volatile than the broader market. Comparatively, Teleflex has a beta of 0.82, suggesting that its stock price is 18% less volatile than the broader market.

Masimo currently has a consensus price target of $180.40, indicating a potential upside of 0.25%. Teleflex has a consensus price target of $146.00, indicating a potential upside of 7.49%. Given Teleflex's stronger consensus rating and higher probable upside, analysts plainly believe Teleflex is more favorable than Masimo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Masimo	0 Sell rating(s)	9 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Teleflex	1 Sell rating(s)	5 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.30

Masimo has higher earnings, but lower revenue than Teleflex. Masimo is trading at a lower price-to-earnings ratio than Teleflex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Masimo	$1.53B	6.17	-$151.50M	-$10.54	N/A
Teleflex	$1.99B	3.02	-$905.64M	-$22.80	N/A

Masimo has a net margin of 4.90% compared to Teleflex's net margin of -35.88%. Masimo's return on equity of 31.33% beat Teleflex's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Masimo	4.90%	31.33%	13.93%
Teleflex	-35.88%	13.29%	6.55%

Summary

Masimo beats Teleflex on 9 of the 15 factors compared between the two stocks.

Get Teleflex News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TFX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TFX vs. The Competition

Export

Metric	Teleflex	MED INSTRUMENTS Industry	Medical Sector	NYSE Exchange
Market Cap	$5.83B	$7.22B	$6.65B	$22.98B
Dividend Yield	1.03%	1.20%	2.67%	4.11%
P/E Ratio	-5.96	48.37	24.73	30.61
Price / Sales	3.02	74.36	507.94	21.22
Price / Cash	11.77	24.77	42.36	23.83
Price / Book	1.92	6.99	10.36	4.64
Net Income	-$905.64M	$159.22M	$3.56B	$1.07B
7 Day Performance	5.45%	-0.79%	-0.96%	0.56%
1 Month Performance	1.99%	2.94%	1.26%	0.06%
1 Year Performance	8.33%	-2.62%	20.46%	20.76%

Teleflex Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TFX Teleflex	3.0264 of 5 stars	$135.82 +3.1%	$146.00 +7.5%	+10.2%	$5.83B	$1.99B	N/A	15,500	Analyst Upgrade
STE STERIS	4.8717 of 5 stars	$212.52 -1.3%	$278.00 +30.8%	-12.5%	$20.86B	$5.94B	26.80	17,787	News Coverage Insider Trade
GMED Globus Medical	4.5525 of 5 stars	$82.00 -0.5%	$106.36 +29.7%	+36.9%	$11.11B	$2.94B	19.07	6,000	Analyst Forecast Insider Trade
PODD Insulet	4.6086 of 5 stars	$144.94 +1.6%	$252.04 +73.9%	-47.8%	$10.04B	$2.71B	33.71	5,400	Analyst Forecast
BAX Baxter International	1.3454 of 5 stars	$18.78 -2.4%	$19.73 +5.0%	-35.1%	$9.70B	$11.32B	N/A	37,500	News Coverage

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:TFX) was last updated on 6/10/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Teleflex (TFX) Competitors